|
PARD6G expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.42359999636355E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.77109999893932E-08 |
| Normal-vs-Stage2 |
4.21370000003307E-07 |
| Normal-vs-Stage3 |
7.98069999974338E-07 |
| Normal-vs-Stage4 |
7.157700E-04 |
| Stage1-vs-Stage2 |
6.238400E-01 |
| Stage1-vs-Stage3 |
5.214000E-01 |
| Stage1-vs-Stage4 |
8.552000E-01 |
| Stage2-vs-Stage3 |
9.417600E-01 |
| Stage2-vs-Stage4 |
8.831400E-01 |
| Stage3-vs-Stage4 |
8.523400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.75581771344469E-12 |
| Normal-vs-AfricanAmerican |
6.82760004089289E-09 |
| Normal-vs-Asian |
1.035380E-01 |
| Caucasian-vs-AfricanAmerican |
3.800100E-02 |
| Caucasian-vs-Asian |
1.365760E-01 |
| AfricanAmerican-vs-Asian |
1.275990E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.76879999536084E-08 |
| Normal-vs-Female |
5.00389999991135E-07 |
| Male-vs-Female |
1.097850E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.37620000132344E-08 |
| Normal-vs-Extreme_Weight |
8.44339997918553E-09 |
| Normal-vs-Obese |
4.85590000431912E-08 |
| Normal-vs-Extreme_Obese |
8.964200E-04 |
| Normal_Weight-vs-Extreme_Weight |
3.350200E-01 |
| Normal_Weight-vs-Obese |
9.313600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.095600E-01 |
| Extreme_Weight-vs-Obese |
2.073800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.108200E-01 |
| Obese-vs-Extreme_Obese |
5.771400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.00059999999613E-05 |
| Normal-vs-Age(41-60Yrs) |
9.30919999975188E-08 |
| Normal-vs-Age(61-80Yrs) |
1.25566224085105E-12 |
| Normal-vs-Age(81-100Yrs) |
2.07920000105943E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.554800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.329180E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.478500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.591400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.777560E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.538800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.01110000372273E-08 |
| Normal-VS-Type2 PRCC |
5.69970000086073E-08 |
| Normal-VS-KIRP CIMP |
4.502000E-02 |
| Normal-VS-Unclassified PRCC |
2.48260000335065E-08 |
| Type1 PRCC-VS-Type2 PRCC |
2.046000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.92598999999571E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
7.277400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.897200E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
5.502400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.722600E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.43450000001222E-07 |
| Normal-vs-N1 |
3.47860000005085E-06 |
| Normal-vs-N2 |
5.707900E-02 |
| N0-vs-N1 |
8.723400E-01 |
| N0-vs-N2 |
8.445600E-01 |
| N1-vs-N2 |
9.114000E-01 |
|
|
